Placental Stem Cell Therapy for Neurological Disorders Market Latest Trends and Future Opportunities Analysis to 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Placental Stem Cell Therapy for Neurological Disorders Market- (By Type (Allogeneic Placental Stem Cell Therapy, Autologous Placental Stem Cell Therapy), By End-User (Hospitals & Specialty Clinics, Clinics Research Organizations, Research Institutes & Academics)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Placental Stem Cell Therapy for Neurological Disorders Market is valued at US$ 384.09 Mn in 2022, and it is expected to reach US$ 2,049.44 Mn by 2031, with a CAGR of 20.6% during a forecast period of 2023-2031.

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2121

The placenta plays a crucial role in facilitating the exchange of gases, nutrients, and waste removal during pregnancy, which is essential for the fetus's well-being. In recent years, the increasing use of human amniotic/amnion epithelial cells (hAECs) in regenerative medicine has led to significant investments in the placental Stem Cell Therapy for Neurological Disorders market. Allogeneic hAECs demonstrate promise in clinical trials for conditions such as leukaemia and bronchopulmonary dysplasia (BPD), contributing to the market's growth, particularly in developed countries where allogeneic stem cell transplantation procedures are on the rise.

The placenta's high cell yield and minimal exposure to infection, originating from an infection-free environment, reduce the risk of disease transmission, making it a major driving factor in the placental Stem Cell Therapy for Neurological Disorders market. Additionally, ongoing advancements in cell-based therapies have spurred industry interest in utilizing placental Stem Cell Therapy for Neurological Disorders for various diseases, including lung and liver injuries, neurological disorders, acute kidney failure, and cardiovascular diseases, further expanding the market's potential.

List of Prominent Players in the Placental Stem Cell Therapy for Neurological Disorders Market:

• Mesoblast Ltd.
• Pleurite Therapeutic
• Remeron Group
• AthersysInc
• Cordlife India
• Life Cell International Pvt. Ltd
• Cryo-Cell International Inc.
• CBR Systems
• Cellularity Inc.
• Cynara
• Others

Market Dynamics:

Drivers-
The regenerative medical approach is utilized to repair damaged cells, rendering it an effective solution for numerous medical conditions. Many businesses are conducting foundational research and preclinical investigations to assess stem cells' potential in regenerating tissues to treat neurological disorders. Notably, substantial investment in cellular therapies for cancer is anticipated to bolster market growth.

The global placental stem cell therapy for neurological disorders market is experiencing rapid growth due to various factors, including surging demand, increased industrialization, heightened consumer awareness, expanding industries, and technological advancements. Sales and revenue within this sector have witnessed exponential growth, and the market's size and expansion are projected to continue increasing in response to these driving factors over the forecasted period.

Challenges:
The lack of standardized protocols, understanding and guidelines for placental stem cell therapy procedures can lead to variability in treatment outcomes and hinder market adoption. Insufficient awareness among healthcare providers and patients about placental stem cell therapies' potential benefits and availability may impede market growth. Ethical considerations related to the use of placental stem cells, including issues surrounding tissue sourcing and informed consent, can pose barriers to market growth. The cost of placental stem cell therapy for neurological disorders can be prohibitively high, limiting its accessibility to a broader patient population.

Regional Trends:
The North American placental stem cell therapy for neurological disorders market is expected to register a major market share. The region's placental Stem Cell Therapy for Neurological Disorders market is primarily driven by the presence of key industry players and their growth strategies. Asia-Pacific region holds the second-largest share in the global placental stem cell therapy for neurological disorders market. The region's robust healthcare sector significantly influences the market's expansion.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/report/placental-stem-cell-therapy-for-neurological-disorders-market/2121

Recent Developments

• In Jan 2021, Celularity Inc. made an announcement regarding the release of the 100th cord blood stem cell unit by its Lifebank subsidiary. This unit will be utilised in an autologous cord blood transplant procedure, specifically aimed at treating an eight-year-old youngster who has been diagnosed with autism spectrum disorder.

Curious about this latest version of the report? Enquiry Before Buying:
Segmentation of Placental Stem Cell Therapy for Neurological Disorders Market-
By Type
• Allogeneic Placental Stem Cell Therapy
• Autologous Placental Stem Cell Therapy

By End-User
• Hospitals & Specialty Clinics
• Clinics Research Organizations
• Research Institutes & Academics

By Region-
North America-
• The US
• Canada
• Mexico

Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-
• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/2121

InsightAce Analytic Pvt. Ltd. Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis of key market insights in a timely and cost-effective manner.

This release was published on openPR.